Immunohistochemical and genetic analysis of respiratory epithelial adenomatoid hamartomas and seromucinous hamartomas: are they precursor lesions to sinonasal low-grade tubulopapillary adenocarcinomas?

Hum Pathol. 2020 Mar:97:94-102. doi: 10.1016/j.humpath.2019.09.018. Epub 2019 Nov 5.

Abstract

Respiratory epithelial adenomatoid hamartoma (REAH) and seromucinous hamartoma (SH) are rare tumor-like lesions of the nasal cavity, paranasal sinuses, and nasopharynx. The pathogenesis of REAH/SH is still unclear. Neoplastic proliferation, chronic mechanical irritation, inflammation, or possible embryological tissue misplacement are speculated as possible mechanisms of their development. Low-grade tubulopapillary adenocarcinoma (LGTA) is a rare variant of nonsalivary, nonintestinal type sinonasal adenocarcinoma. The aim of this study was to evaluate the immunohistochemical and genetic profiles of 10 cases of REAH/SH, with serous, mucinous, and respiratory components evaluated separately and to compare these findings with the features of 9 cases of LGTA. All cases of REAH/SH and LGTA were analyzed immunohistochemically with a cocktail of mucin antigens (MUC1, MUC2, MUC4, MUC5AC, MUC6) and with epithelial (CK7, CK20, CDX2, SATB2) and myoepithelial markers (S100 protein, p63, SOX10). The next-generation sequencing assay was performed using FusionPlex Solid Tumor Kit (ArcherDx) in 10 cases of REAH/SH, and the EGFR-ZNF267 gene fusion was detected in 1 of them. Two female REAH/SH cases were assessed for the presence of clonality. Using the human androgen receptor assay, 1 case was proved to be clonal. The serous component of REAH/SH was positive for CK7/MUC1 and SOX10 similarly to LGTA. Although REAH/SH and LGTA are histopathologically and clinically separate entities, the overlap in their morphological and immunohistochemical profiles suggests that REAH/SH might be a precursor lesion of LGTA.

Keywords: Low-grade tubulopapillary adenocarcinoma; Nasal cavity; REAH; Respiratory epithelial adenomatoid hamartoma; Seromucinous hamartoma; Sinonasal tract.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / chemistry
  • Adenocarcinoma / diagnosis*
  • Adenocarcinoma / genetics
  • Adenocarcinoma / pathology
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor* / analysis
  • Biomarkers, Tumor* / genetics
  • Child
  • Diagnosis, Differential
  • Female
  • Hamartoma / chemistry
  • Hamartoma / diagnosis*
  • Hamartoma / genetics
  • Hamartoma / pathology
  • Humans
  • Immunohistochemistry*
  • Male
  • Middle Aged
  • Molecular Diagnostic Techniques*
  • Nasal Mucosa / chemistry*
  • Nasal Mucosa / pathology
  • Nasopharyngeal Diseases / diagnosis*
  • Nasopharyngeal Diseases / genetics
  • Nasopharyngeal Diseases / metabolism
  • Nasopharyngeal Diseases / pathology
  • Neoplasm Grading
  • Nose Diseases / diagnosis*
  • Nose Diseases / genetics
  • Nose Diseases / metabolism
  • Nose Diseases / pathology
  • Nose Neoplasms / chemistry
  • Nose Neoplasms / diagnosis*
  • Nose Neoplasms / genetics
  • Nose Neoplasms / pathology
  • Precancerous Conditions / diagnosis*
  • Precancerous Conditions / genetics
  • Precancerous Conditions / metabolism
  • Precancerous Conditions / pathology
  • Predictive Value of Tests
  • Young Adult

Substances

  • Biomarkers, Tumor